Benedikt Stefansson
Contatto Relazioni con gli Investitori presso ALVOTECH
Posizioni attive di Benedikt Stefansson
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALVOTECH | Contatto Relazioni con gli Investitori | 02/03/2022 | - |
Public Communications Contact | 02/03/2022 | - |
Storia della carriera di Benedikt Stefansson
Precedenti posizioni note di Benedikt Stefansson
Società | Posizione | Inizio | Fine |
---|---|---|---|
CRI hf.
CRI hf. Chemicals: SpecialtyProcess Industries CRI hf. captures carbon dioxide from industrial emissions and converts carbon dioxide into renewable methanol. It produces renewable methanol from carbon dioxide, hydrogen and electricity for energy storage, fuel applications and enhancement. The firm serves the following industries: bio diesel production, chemicals, gasoline blending, and wastewater treatment industries. Its services include project partnership, feasibility to investment, project execution, and lifetime operation services. The company was founded by Oddur Ingólfsson, Arthur Shulenberger, Fridrik Jonsson, and K-C Tran in 2006 and is headquartered in Kopavogur, Iceland. | Corporate Officer/Principal | - | - |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Vendite & Marketing | - | - |
Landsbanki Research | Analyst-Equity | - | - |
Formazione di Benedikt Stefansson
University of California, Los Angeles | Graduate Degree |
Statistiche
Distribuzione geografica
Islanda | 4 |
Stati Uniti | 2 |
Lussemburgo | 2 |
Posizioni
Analyst-Equity | 1 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALVOTECH | Health Technology |
Aziende private | 3 |
---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
Landsbanki Research | |
CRI hf.
CRI hf. Chemicals: SpecialtyProcess Industries CRI hf. captures carbon dioxide from industrial emissions and converts carbon dioxide into renewable methanol. It produces renewable methanol from carbon dioxide, hydrogen and electricity for energy storage, fuel applications and enhancement. The firm serves the following industries: bio diesel production, chemicals, gasoline blending, and wastewater treatment industries. Its services include project partnership, feasibility to investment, project execution, and lifetime operation services. The company was founded by Oddur Ingólfsson, Arthur Shulenberger, Fridrik Jonsson, and K-C Tran in 2006 and is headquartered in Kopavogur, Iceland. | Process Industries |
- Borsa valori
- Insiders
- Benedikt Stefansson
- Esperienza